PARIS (EGMN) - Patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis do not have an increased rate of underlying malignancies, according to the findings of a large Danish case-control study."The overall message of our study is that as a clinician you don't have to screen your patients with newly diagnosed [antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis] for any underlying cancer on a routine basis," Dr. Mikkel Faurschou said at the annual congress...